Faculty profile

Tamàs Fulop

ResearcherPédiatrieUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Tamàs Fulop

Researcher

Pédiatrie

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
27 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (5 CIHR, 1 NSERC), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

113

Publications

208

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Aging Autoimmune Disease Chronic Inflammation Cytokine Signaling Cytokines Immune Cells Metabolic Disorders Obesity

Latest papers

Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.
Journal of Alzheimer's disease : JAD · 2026 · first author
Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta1-42-induced neurodegeneration.
Mechanisms of ageing and development · 2026 · senior author
A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment.
Alzheimer's & dementia (New York, N. Y.) · 2026

All 113 publications

Latest funding

Decoding and challenging choroid plexus inflammation in the aging brain
CIHR · 2024 · Co-investigator
$1,071,000
Clinicopatholgical correlates of long COVID and potential interventions for improving the quality of life
CIHR · 2021 · Co-investigator
$490,000
Imaging the contribution of early cerebrovascular inflammation in Alzheimer's disease
CIHR · 2021 · Co-investigator
$1,002,150

All 18 grants and awards

113 publications.

Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.

Fulop T, Cohen AA, Frost EH, Lévesque S, Khalil A, Rodrigues S, Desroches M, Alami M, Berrougui H, Ramassamy C, Hirokawa K, Witkowski JM, Laurent B

Journal of Alzheimer's disease : JAD2026First author

DOI: 10.1177/13872877251415571 PMID: 41593034

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta1-42-induced neurodegeneration.

Alami M, Berrougui H, Boumezough K, Salih I, Sadki K, Laurent B, van Tellingen O, Bunt T, Khalil A, Fulop T

Mechanisms of ageing and development2026Senior author

DOI: 10.1016/j.mad.2026.112161 PMID: 41707918

A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment.

Roy M, Fortier M, St-Pierre V, Morin MC, Boré A, Edde M, Vandenberghe C, Groulx K, Croteau É, Richard G, Thoumyre S, Fulop T, Bocti C, Rheault F, Cuenoud B, Descoteaux M, Cunnane SC

Alzheimer's & dementia (New York, N. Y.)2026

DOI: 10.1002/trc2.70278 PMID: 42344884

Th1/Th2 immune regulation and functional resilience in older adults following severe COVID-19: a prospective cohort study.

Cataneo-Piña D, Chávez-Galán L, Ocaña-Guzmán R, Ávila-Funes JA, Fulop T, Buendia-Roldan I

European geriatric medicine2026

DOI: 10.1007/s41999-025-01293-x PMID: 40886226

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ1-42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.

Alami M, Zerif E, Khalil A, Hajji N, Ramassamy C, Lacombe G, Laurent B, Cohen AA, Wikowski JM, Gris D, Bunt T, van Tellingen O, Hirokawa K, Fulop T, Berrougui H

Journal of Alzheimer's disease : JAD2025

DOI: 10.1177/13872877251329474 PMID: 40111935

Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis.

Mohammadi S, Fulop T, Khalil A, Ebrahimi S, Hasani M, Ziaei S, Farsi F, Mirtaheri E, Afsharianfar M, Heshmati J

BMC complementary medicine and therapies2025

DOI: 10.1186/s12906-025-04819-9 PMID: 39987124

Exploring the potential of plasma and adipose mesenchymal stem cell-derived extracellular vesicles as novel platforms for neuroinflammation therapy.

Silva RO, Haddad M, Counil H, Zaouter C, Patten SA, Fulop T, Ramassamy C

Journal of controlled release : official journal of the Controlled Release Society2025

DOI: 10.1016/j.jconrel.2024.11.060 PMID: 39617173

Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation.

Hermann DM, Bacigaluppi M, Bassetti CL, Bassotti G, Boltze J, Chan A, Dalkara T, Denes A, Diez-Tejedor E, Dodel R, Doeppner TR, Dzyubenko E, ElAli A, Fulop T, Gerhard A, Giebel B, Gronewold J, Gunzer M, Heinbockel T, Huang K, Iriti M, Karnath HO, Trenite KN, Kilic E, Lanza G, Liesz A, Magnus TU, Mandrioli J, Mohamud-Yusuf A, Müller T, Pan S, Peruzzotti-Jametti L, Pluchino S, Pluta R, Popa-Wagner A, Rezayof A, Seghier ML, Shu X, Singh V, Sipilä J, Slevin M, Tang Y, Tsivgoulis G, Varrassi G, Wang C, Yilmaz B, Zaki MS, Zhang J

Exploration of neuroscience2025

DOI: 10.37349/en.2025.1006106 PMID: 40856238

No Consistent Evidence that Ageism Is Linked to Biological Aging Status in the US Health and Retirement Study.

Liu M, Cohen AA, Legault V, Honfo SH, Tanner K, Fulop T, Levasseur M

Gerontology2025

DOI: 10.1159/000543253 PMID: 40552858

Biological Activities Underlying the Cardiovascular Benefits of Olive Oil Polyphenols: Focus on Antioxidant, Anti-Inflammatory, and Anti-Atherogenic Effects.

Boumezough K, Alami M, Fulop T, Zoubdane N, Salih I, Ramchoun M, Khalil A, Berrougui H

International journal of molecular sciences2025

DOI: 10.3390/ijms262211165 PMID: 41303649

Something wrong or missing on this profile? Suggest a correction

Tamàs Fulop

Research

Latest papers

Latest funding

Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta1-42-induced neurodegeneration.

A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment.

Th1/Th2 immune regulation and functional resilience in older adults following severe COVID-19: a prospective cohort study.

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on A&#x3b2;1-42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.

Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis.

Exploring the potential of plasma and adipose mesenchymal stem cell-derived extracellular vesicles as novel platforms for neuroinflammation therapy.

Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation.

No Consistent Evidence that Ageism Is Linked to Biological Aging Status in the US Health and Retirement Study.

Biological Activities Underlying the Cardiovascular Benefits of Olive Oil Polyphenols: Focus on Antioxidant, Anti-Inflammatory, and Anti-Atherogenic Effects.

Frequent collaborators

Abdelouahed Khalil

Benoit Laurent

Olivier Lesur

Mark Loeb

Stephen Walter

Jonathan Bramson

Martin Lepage

Shelly McNeil

Philip Devereaux

Janet McElhaney

Kevin Whittingstall

Ayman ElAli

Jennie Johnstone

Mahsa Dadar

Sylvain Giroux

Nathalie Bier

Danielle Laurin

Simon Duchesne

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ1-42-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.